Mostrar el registro sencillo del ítem

dc.contributor.authorRojo, David
dc.contributor.authorHevia, Arancha
dc.contributor.authorBargiela, Rafael
dc.contributor.authorLópez, Patricia
dc.contributor.authorCuervo, Adriana
dc.contributor.authorGonzález, Sonia
dc.contributor.authorSuárez, Ana
dc.contributor.authorSánchez, Borja
dc.contributor.authorMartínez-Martínez, Mónica
dc.contributor.authorMilani, Christian
dc.contributor.authorVentura, Marco
dc.contributor.authorBarbas, Coral
dc.contributor.authorMoya, Andrés
dc.contributor.authorSuárez García, Antonio
dc.contributor.authorMargolles, Abelardo
dc.contributor.authorFerrer, Manuel
dc.date.accessioned2015-04-24T10:52:28Z
dc.date.available2015-04-24T10:52:28Z
dc.date.issued2015
dc.identifier.citationRojo, D.; et al. Ranking the impact of human health disorders on gut metabolism: Systemic lupus erythematosus and obesity as study cases. Scientific Reports, 5: 8310 (2015). [doi: 10.1038/srep08310]es_ES
dc.identifier.issn2045-2322
dc.identifier.urihttp://hdl.handle.net/10481/35792
dc.description.abstractMultiple factors have been shown to alter intestinal microbial diversity. It remains to be seen, however, how multiple collective pressures impact the activity in the gut environment and which, if any, is positioned as a dominant driving factor determining the final metabolic outcomes. Here, we describe the results of a metabolome-wide scan of gut microbiota in 18 subjects with systemic lupus erythematosus (SLE) and 17 healthy control subjects and demonstrate a statistically significant difference (p < 0.05) between the two groups. Healthy controls could be categorized (p < 0.05) based on their body mass index (BMI), whereas individuals with SLE could not. We discuss the prevalence of SLE compared with BMI as the dominant factor that regulates gastrointestinal microbial metabolism and provide plausible explanatory causes. Our results uncover novel perspectives with clinical relevance for human biology. In particular, we rank the importance of various pathophysiologies for gut homeostasis.es_ES
dc.description.sponsorshipThe present investigation was funded by the Spanish Ministry of Economy and Competitiveness and the Federal Ministry of Education and Research (BMBF) within the ERA NET PathoGenoMics2 program, grant number 0315441A. This work was further funded by grants BFU2008-04501-E, BFU2008-04398-E, SAF2009-13032-C02-01, SAF2012-31187 and CSD2007-00005, BIO2011-25012, AGL2010-14952 and AGL2006-11697/ALI from the Spanish Ministry of Economy and Competitiveness, and Prometeo/2009/092 from Generalitat Valenciana (Spain). The authors gratefully acknowledge the financial support provided by the European Regional Development Fund (ERDF).es_ES
dc.language.isoenges_ES
dc.publisherNature Publishing Groupes_ES
dc.rightsCreative Commons Attribution-NonCommercial-NoDerivs 3.0 Licensees_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es_ES
dc.subjectAutoimmunityes_ES
dc.subjectMicrobiomees_ES
dc.subjectObesity es_ES
dc.titleRanking the impact of human health disorders on gut metabolism: Systemic lupus erythematosus and obesity as study caseses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.doi10.1038/srep08310


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License
Excepto si se señala otra cosa, la licencia del ítem se describe como Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License